| Stage | NVDA | % of rev | ALGM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $96.2B | 100.00% | $277M | 100.00% | NVDA ×347.51 |
| Gross profit | $72.1B | 74.98% | $136M | 49.18% | NVDA +25.8pp |
| Operating income | $63.7B | 66.24% | $35M | 12.80% | NVDA +53.4pp |
| Pre-tax income | $71.5B | 74.32% | $28M | 10.05% | NVDA +64.3pp |
| Net income | $59.7B | 62.03% | $23M | 8.42% | NVDA +53.6pp |
| Stage | NVDA | ALGM | Gap · A − B |
|---|---|---|---|
| Revenue | $96.2B100.00% | $277M100.00% | NVDA ×347.51 |
| Gross profit | 74.98%$72.1B | 49.18%$136M | NVDA +25.8pp |
| Operating income | 66.24%$63.7B | 12.80%$35M | NVDA +53.4pp |
| Pre-tax income | 74.32%$71.5B | 10.05%$28M | NVDA +64.3pp |
| Net income |
| 62.03%$59.7B |
| 8.42%$23M |
| NVDA +53.6pp |
No shared counterparties.